Menu

Safety guide · 3 min read

Compounded GLP-1s are not FDA-approved, and that difference matters.

The short answer

FDA-approved GLP-1 medicines, such as Wegovy and Zepbound, passed FDA review for safety, effectiveness and quality. Compounded versions did not. A licensed pharmacy prepares them for an individual patient. They are not generic copies and are not equivalent to the brands. FDA has reported dosing errors and adverse events with compounded GLP-1s, so pharmacy quality and clear instructions matter.

Livozo expects to offer clinician-reviewed access to semaglutide and tirzepatide through a licensed clinical partner. Care is not live today. This guide does not recommend a specific medication.

What FDA approval means

Before FDA approves a drug, the agency reviews evidence on its safety, effectiveness and manufacturing quality. The approved label then sets out uses, warnings, storage and dosing. Wegovy and Zepbound are FDA-approved GLP-1 medicines for weight management.[1][2]

Compounded drugs are not FDA-approved. FDA does not verify their safety, effectiveness or quality before they are marketed.[3]

What compounding is

Compounding is the preparation of a drug for an individual patient. Under section 503A, licensed pharmacists in state-licensed pharmacies compound drugs for specific prescriptions. These pharmacies are not held to federal current good manufacturing practice rules.[3]

Under section 503B, outsourcing facilities register with FDA, face risk-based FDA inspections and must meet current good manufacturing practice rules. Even so, a drug made there is still not an FDA-approved drug.[3]

A compounded GLP-1 is never a generic, an equivalent or a substitute for a branded medicine. Trials such as STEP 1 and SURMOUNT-1 studied the branded products, so their results do not transfer automatically to compounded versions.

What FDA has warned about

FDA has received reports of adverse events linked to compounded semaglutide and compounded tirzepatide. The agency also warns that illegally sold products may be counterfeit or contain the wrong or harmful ingredients.[4]

Some reports involved dosing errors. Patients drew up more than the prescribed amount from multiple-dose vials, sometimes five to 20 times more. Confusion between milliliters, milligrams and units, and syringes that were too large, added to the problem. Some people needed hospital care.[5]

What to check before using any GLP-1

Get the prescription from a licensed clinician who reviewed your history. Fill it at a state-licensed pharmacy. FDA's BeSafeRx program explains how to spot an online seller that may be unsafe.[6]

Read the label before the first dose. It should show your name, the medicine, its strength, how much to use, the beyond-use date and how to store it. FDA advises throwing away multiple-dose vials 28 days after first use and not using an injectable GLP-1 that arrives warm.[4]

If something goes wrong, contact the prescribing clinician. You can also report a side effect or product problem to FDA through its MedWatch program.

What we know

  • Compounded drugs are not FDA-approved, and FDA does not review them before they are marketed.
  • 503B outsourcing facilities face FDA inspection and manufacturing rules. 503A pharmacies do not face federal manufacturing rules.
  • FDA has received adverse event reports, including dosing errors, linked to compounded GLP-1s.

What we don't know yet

  • How the quality of compounded GLP-1s varies from one pharmacy to another.
  • Whether trial results for branded products apply to any given compounded preparation.
  • The full rate of problems, because adverse event reporting is voluntary and incomplete.

Safety

  • Use the syringe the pharmacy provides and ask the pharmacist to show you how to measure your dose.
  • Seek urgent care for severe vomiting, signs of dehydration or severe stomach pain.
  • Do not buy GLP-1 medicines from sellers that do not need a prescription.

This guide is education, not medical advice. It does not create a clinician-patient relationship. If you think you are having an emergency, call 911.

Sources

  1. DailyMed (NLM) — Wegovy (semaglutide) prescribing information
  2. DailyMed (NLM) — Zepbound (tirzepatide) prescribing information
  3. FDA — Compounding and the FDA: questions and answers
  4. FDA — FDA's concerns with unapproved GLP-1 drugs used for weight loss
  5. FDA — Dosing errors associated with compounded injectable semaglutide products
  6. FDA — BeSafeRx: your source for online pharmacy information

Keep reading.